TNF and chronic inflammatory demyelinating polyradiculoneuropathy: Increase in the dosage is not recommended, as high-dose IVIG is strongly associated with hemolytic anemia,20 Recently, IVIG plus infliximab (monoclonal antibody against TNF) was used versus IVIG alone to evaluate the effects of combination therapy.21 In addition, IVIG was further used as an effective treatment for acute and chronic inflammatory neuropathies, Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).